Literature DB >> 7857114

A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses.

N Lawrence1, S E Cox, C J Cockerell, R G Freeman, P D Cruz.   

Abstract

BACKGROUND AND
DESIGN: We compared the efficacy and safety of a medium-depth chemical peel with those of the standard regimen of topical fluorouracil in the treatment of widespread facial actinic keratoses (AK). Fifteen patients with severe facial actinic damage and similar numbers of AK on both sides of the face were treated on the left side with a single application of Jessner's solution and 35% trichloroacetic acid and on the right side with twice daily applications of 5% fluorouracil cream for 3 weeks. Evaluations were conducted before treatment and at 1, 6, and 12 months after treatment. Visible AK were counted, random skin biopsies performed, adverse effects monitored, and patients questioned about preference and perception of efficacy.
RESULTS: Both treatments reduced the number of visible AK by 75% and produced equivalent reductions in keratinocyte atypia, hyperkeratosis, parakeratosis, and inflammation, with no significant alteration of preexisting solar elastosis and telangiectasia. Except for erythema that lasted 3 months in one patient, no untoward side effects were observed with the chemical peel. The majority of patients preferred the peel over fluorouracil because of the single application and less morbidity.
CONCLUSION: The medium-depth peel induced by Jessner's solution and 35% trichloroacetic acid is a useful alternative therapeutic option for widespread facial AK, particularly for poorly compliant patients, because it equals fluorouracil in efficacy while being superior in terms of the convenience of a single application with little associated morbidity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7857114

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

1.  Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing.

Authors:  Marta I Rendon; Diane S Berson; Joel L Cohen; Wendy E Roberts; Isaac Starker; Beatrice Wang
Journal:  J Clin Aesthet Dermatol       Date:  2010-07

2.  Topical imiquimod therapy for actinic keratosis: is long-term clearance a realistic benefit?

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

Review 3.  [Topical treatment of skin aging].

Authors:  C Bayerl
Journal:  Hautarzt       Date:  2005-04       Impact factor: 0.751

Review 4.  Actinic keratoses. Differential diagnosis and treatment.

Authors:  J W Barnaby; A R Styles; C J Cockerell
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

5.  [Topical therapy of squamous cell carcinoma].

Authors:  U R Hengge
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

Review 6.  Wounding Therapies for Prevention of Photocarcinogenesis.

Authors:  Timothy C Frommeyer; Craig A Rohan; Dan F Spandau; Michael G Kemp; Molly A Wanner; Elizabeth Tanzi; Jeffrey B Travers
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.